Free US stock put/call ratio analysis and sentiment contrarian indicators for market timing signals. We monitor options market activity to understand when markets might be too bullish or bearish.
Celcuity Inc. (CELC) is a biotech firm whose shares are trading at $141.69 as of May 5, 2026, marking a recent 2.27% decline from prior closing levels. This analysis explores current market context, key technical support and resistance levels, and potential near-term trading scenarios for the stock. No recent earnings data is available for Celcuity Inc. as of this writing, so technical factors and broader sector trends are the primary focus of this update. The stock has traded in a relatively ti
Why Celcuity (CELC) valuation makes sense when you dig deeper (Momentum Fading) 2026-05-05 - Asset Allocation
CELC - Stock Analysis
4468 Comments
1714 Likes
1
Teneeka
Returning User
2 hours ago
Missed the notice… oof.
👍 263
Reply
2
Monnica
Experienced Member
5 hours ago
I feel like I just agreed to something.
👍 172
Reply
3
Ivanshika
Expert Member
1 day ago
Ah, if only I had caught this before. 😔
👍 185
Reply
4
Sadena
Consistent User
1 day ago
So late… oof. 😅
👍 140
Reply
5
Neyo
Engaged Reader
2 days ago
Anyone else here for answers?
👍 66
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.